secwatch.observer — SEC 8-K summary
======================================

Issuer:     Theriva Biologics, Inc. (TOVX)
CIK:        0000894158
Form:       8-K
Filed at:   2025-12-15T23:59:59+00:00
Accession:  0001104659-25-121246
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Theriva Biologics special meeting fails due to lack of quorum; new meeting to be called
--------------------------------------------------------------------------------

- Special Meeting of Stockholders convened Dec. 15, 2025 lacked sufficient shares for quorum.
- Company will call a new special meeting to seek stockholder approval for warrant exercise proposal.
- Under Oct. 16, 2025 Inducement Agreement, company must hold meetings every 60 days until approval or warrants lapse.
- Approval sought for issuance of up to 16,184,560 shares of common stock upon exercise of New Warrants.
- Company will file and mail proxy materials for the new meeting, date and time to be announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/894158/000110465925121246/0001104659-25-121246-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/894158/000110465925121246/tm2533572d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-121246

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer